In addition, the tumour suppressive effect was maintained until the monitoring end‐point, with the tumour fluorescent intensity values of 3.85 ± 1.64 for the CD19‐positive and 8.18 ± 1.68 for the CD19‐negative group on day 13 (P = .0005). The gene discussed is CD19; the disease is neoplasm.